SAL Trading’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,800
Closed -$891K 33
2023
Q3
$891K Sell
9,800
-7,400
-43% -$652K 1.25% 20
2023
Q2
$1.39M Buy
17,200
+10,000
+139% +$817K 1.56% 16
2023
Q1
$573K Sell
7,200
-9,600
-57% -$681K 0.3% 29
2022
Q4
$1.14M Buy
+16,800
New +$985K 0.66% 17
2022
Q1
Sell
-4,200
Closed -$235K 57
2021
Q4
$235K Buy
+4,200
New +$228K 0.1% 28

Other funds holding NVO

SAL Trading's NVO Position: Q2 2022 in Review

SAL Trading sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 107,800 shares — an estimated $5.98M sold.

SAL Trading first reported a position in NVO in Q4 2021 and held it in 2 quarters. The position peaked at $5.99M in Q1 2022. 934 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

  • SAL Trading reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
  • SAL Trading sold 107,800 Novo Nordisk shares in Q2 2022, an estimated $5.98M.
  • SAL Trading first reported a position in Novo Nordisk in Q4 2021 and held it in 2 quarters.
  • SAL Trading's Novo Nordisk position peaked at $5.99M in Q1 2022.
  • 934 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on SAL Trading's 13F filing for Q2 2022, filed 15 Aug 2022.